ATE88718T1 - Verfahren zur reinigung des hepatitis-oberflaechen-antigens und das so erhaltene produkt. - Google Patents

Verfahren zur reinigung des hepatitis-oberflaechen-antigens und das so erhaltene produkt.

Info

Publication number
ATE88718T1
ATE88718T1 AT85304849T AT85304849T ATE88718T1 AT E88718 T1 ATE88718 T1 AT E88718T1 AT 85304849 T AT85304849 T AT 85304849T AT 85304849 T AT85304849 T AT 85304849T AT E88718 T1 ATE88718 T1 AT E88718T1
Authority
AT
Austria
Prior art keywords
purification
surface antigen
product
hepatitis surface
hepatitis
Prior art date
Application number
AT85304849T
Other languages
English (en)
Inventor
Robert David Hershberg
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24522405&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE88718(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of ATE88718T1 publication Critical patent/ATE88718T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Detergent Compositions (AREA)
AT85304849T 1984-07-09 1985-07-08 Verfahren zur reinigung des hepatitis-oberflaechen-antigens und das so erhaltene produkt. ATE88718T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/629,295 US4624918A (en) 1984-07-09 1984-07-09 Purification process for hepatitis surface antigen and product thereof
EP85304849A EP0168234B1 (de) 1984-07-09 1985-07-08 Verfahren zur Reinigung des Hepatitis-Oberflächen-Antigens und das so erhaltene Produkt

Publications (1)

Publication Number Publication Date
ATE88718T1 true ATE88718T1 (de) 1993-05-15

Family

ID=24522405

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85304849T ATE88718T1 (de) 1984-07-09 1985-07-08 Verfahren zur reinigung des hepatitis-oberflaechen-antigens und das so erhaltene produkt.

Country Status (5)

Country Link
US (1) US4624918A (de)
EP (1) EP0168234B1 (de)
JP (1) JPH0675B2 (de)
AT (1) ATE88718T1 (de)
DE (1) DE3587298T2 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8597910B1 (en) 1985-04-11 2013-12-03 Children's Medical Center Corporation DNA encoding Von Willebrand Factor (VWF) and methods and cells for producing VFW, and VFW produced by the DNA, methods and cells
FR2608052B1 (fr) * 1986-12-10 1990-04-13 Pasteur Vaccins Procede de preparation d'un vaccin contre l'hepatite b et vaccin obtenu
US5026828A (en) * 1987-02-27 1991-06-25 Merck & Co., Inc. Method of purifying recombinant pres-1/S-2/S/S hepatitis B antigen from yeast
EP0294071A3 (de) * 1987-06-03 1990-08-01 Merck & Co. Inc. Impfstoffe gegen Hepatitis B hergestellt mit vorherhergestellten Aluminiumhydroxydengelen und Verfahren zu deren Herstellung
US5011915A (en) * 1987-10-26 1991-04-30 Merck & Co., Inc. Process for purifying recombinant hepatitis antigens
US5004688A (en) * 1988-04-15 1991-04-02 Phillips Petroleum Company Purification of hepatitis proteins
EP0384058A1 (de) * 1989-02-09 1990-08-29 Development Center For Biotechnology Isolierung des Hepatitis-B-Oberflächenantigens von transformierten Hefezellen
US5462863A (en) * 1989-02-09 1995-10-31 Development Center For Biotechnology Isolation of Hepatitis B surface antigen from transformed yeast cells
CU22290A1 (es) * 1990-10-08 1995-01-31 Cigb Procedimiento para la obtencion de antigeno de superficie del virus de la hepatitis b de superior capacidad inmunoganica y su uso en un preparado vacunal
IT1248075B (it) * 1991-06-18 1995-01-05 Sclavo Spa Processo per la purificazione del virus dell'epatite a (hav), virus cosi` purificato e composizioni vaccinali che lo contengono.
DE69319728T2 (de) * 1992-05-23 1999-02-04 Smithkline Beecham Biolog Kombinierte Impfstoffe, die Hepatitis B oberfläche Antigen und andere Antigenen enthalten
US5709995A (en) 1994-03-17 1998-01-20 The Scripps Research Institute Hepatitis C virus-derived peptides capable of inducing cytotoxic T lymphocyte responses
IL118626A0 (en) * 1996-06-11 1996-10-16 Xtl Biopharmaceuticals Limited Anti HBV antibody
US7998705B2 (en) * 2002-08-06 2011-08-16 FUJIFILM Diosynth Biotechnologies U.S.A., Inc Increased dynamic binding capacity in ion exchange chromatography by addition of polyethylene glycol
US9603921B2 (en) * 2004-10-27 2017-03-28 Janssen Vaccines Ag Virosome particles comprising antigens from influenza virus and hepatitis b virus
GB0522765D0 (en) * 2005-11-08 2005-12-14 Chiron Srl Combination vaccine manufacture
DE102011122891B4 (de) 2011-11-11 2014-12-24 Novartis Ag Fermentationsmedium, das frei von tierischen Bestandteilen ist, zur Herstellung von Diphtherie-Toxoiden zur Verwendung bei der Impfung von Menschen
DE102011118371B4 (de) 2011-11-11 2014-02-13 Novartis Ag Zur Impfung von Menschen geeignete Zusammensetzung, die ein Diphtherie-Toxoid umfasst, sowie Verfahren zu deren Herstellung
GB2495341B (en) 2011-11-11 2013-09-18 Novartis Ag Fermentation methods and their products
EP2592137A1 (de) 2011-11-11 2013-05-15 Novartis AG Fermentierungsmedium ohne Bestandteile tierischen Ursprungs zur Herstellung von Diphtherie-Impfstoffen zur menschlichen Impfung
CA2886938A1 (en) 2012-10-12 2014-04-17 Glaxosmithkline Biologicals S.A. Non-cross-linked acellular pertussis antigens for use in combination vaccines

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3994870A (en) * 1974-01-31 1976-11-30 The Community Blood Council Of Greater New York, Inc. Purification of hepatitis B surface antigen
US4186193A (en) * 1975-06-16 1980-01-29 Merck & Co., Inc. Hepatitis B antigen
JPS5840930B2 (ja) * 1976-09-20 1983-09-08 株式会社ミドリ十字 Ｂ型肝炎ワクチンの製造方法
US4088748A (en) * 1976-11-02 1978-05-09 Merck & Co., Inc. Hepatitis B surface antigen
US4162192A (en) * 1978-09-28 1979-07-24 Juridical Foundation Method for purification of HBs antigen
US4181713A (en) * 1978-10-30 1980-01-01 Merck & Co., Inc. Isolation of HBs Ag
US4271145A (en) * 1979-10-22 1981-06-02 The Massachusetts General Hospital Process for producing antibodies to hepatitis virus and cell lines therefor
US4349539A (en) * 1980-08-15 1982-09-14 Merck & Co., Inc. Separation of hepatitis B surface antigen
EP0062574A3 (de) * 1981-03-31 1982-12-29 The Regents Of The University Of California Synthese von Virusproteinen
GR76274B (de) * 1981-08-04 1984-08-04 Univ California
NZ201705A (en) * 1981-08-31 1986-03-14 Genentech Inc Recombinant dna method for production of hepatitis b surface antigen in yeast
US4442205A (en) * 1981-09-22 1984-04-10 The United States Of America As Represented By The Department Of Health And Human Services Simian virus recombinant that directs the synthesis of hepatitis B surface antigen
JPS5936698A (ja) * 1982-08-20 1984-02-28 Science & Tech Agency Ｂ型肝炎ウイルス遺伝子を組込んだ組換えｄｎａおよび形質転換動物細胞

Also Published As

Publication number Publication date
US4624918A (en) 1986-11-25
EP0168234A2 (de) 1986-01-15
JPS6136228A (ja) 1986-02-20
DE3587298D1 (de) 1993-06-03
JPH0675B2 (ja) 1994-01-05
EP0168234A3 (en) 1988-09-14
EP0168234B1 (de) 1993-04-28
DE3587298T2 (de) 1993-10-21

Similar Documents

Publication Publication Date Title
ATE88718T1 (de) Verfahren zur reinigung des hepatitis-oberflaechen-antigens und das so erhaltene produkt.
DE3886577T2 (de) Verfahren zur Reinigung von tertiären Organophosphiten.
DE69637509D1 (de) Verfahren zur reinigung von faktor-ix
DK0414275T3 (da) Fremgangsmåde til fremtilling af cycliske aminosyrederivater samt mellemprodukter
DE3882642T2 (de) Substituierte tetraline, chromane und verwandte verbindungen fuer die behandlung von asthma, arthritis und verwandte krankheiten.
DE3486210T2 (de) Verfahren zum Herstellen von Polsterartikeln.
DE69021658D1 (de) Verfahren zum Wärmebehandeln von Metallen.
DE69005959T2 (de) Verfahren zur Reinigung von menschlichem Serum-Albumin.
DE69003423D1 (de) Verfahren zur Reinigung von 1,1,1,2-Tetrafluorethan.
DE69004229D1 (de) Verfahren zur Reinigung von 1,1-Dichlor-1-fluorethan.
ATE47883T1 (de) Verfahren zur selektiven erhoehung des anteiles von einzelnen hauptkomponenten des teicoplanin a2-komplexes.
DE69016879D1 (de) Verfahren zur Reinigung von N-Phosphonmethylglyzin.
DE3861445D1 (de) Verfahren zur destillativen reinigung von tetrahydrofuran.
DE68907326T2 (de) Verfahren zur kontinuierlichen Reinigung von Bisphenolen.
ATE173272T1 (de) Verfahren zur reaktivierung von gereinigten membranproteinen
DE59008624D1 (de) Verfahren zum Herstellen von kaschierten Formteilen.
DE68908801T2 (de) Verfahren zur Reinigung von Dihydroxyphenolen.
DE3882411T2 (de) Verfahren zur Trennung von aktiviertem menschlichem Protein C.
DE59100288D1 (de) Verfahren zur aufarbeitung des sumpfproduktes von extraktivdestillationsprozessen zur gewinnung reiner aromaten.
DE3888260T2 (de) Verfahren zum Herstellen von Kohlenstoffmaterialien.
AT339923B (de) Verfahren zur destillativen reinigung von 2,5-dioxo -1-oxa-2- phospholanen
DE69521281D1 (de) Verfahren zur Herstellung von menschlichem oder humanem Matrilysin mittels rekombinanter DNA.
DE3850056T2 (de) Verfahren zur Regeneration von desaktivierten Mikroorganismen.
DE58903279D1 (de) Vorrichtung zum herstellen von huettenbims.
DE69011065D1 (de) Verfahren zur Behandlung von Nickel-Magnesium-Silikaterzen.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time